Results 311 to 320 of about 87,481 (331)

Radiofluorinated Analogs of NCS-382 as Potential PET Tracers for Imaging the CaMKIIα Hub Domain. [PDF]

ACS Chem Neurosci
Sirocchi LS, Stotz S, Müller M, Pedersen NB, Thiesen L, Mattiussi S, Avgerinos C, Shalgunov V, Wellendorph P, Fro̷lund B, Herth MM.   +10 more
europepmc   +1 more source

Advances in Molecular Imaging of VEGFRs: Innovations in Imaging and Therapeutics. [PDF]

Int J Mol Sci
Karimi H, Lee S, Xu W, Langhans SA, Johnson DK, Stauff E, Kecskemethy HH, Averill LW, Yue X.   +8 more
europepmc   +1 more source

Homeostatic response of phospholipid pathways to PCYT2 deficiency and impaired de Novo synthesis of phosphatidylethanolamine. [PDF]

Sci Rep
Iraji R, St Germain M, Grapentine S, Perreira L, Schenkel L, Al-Douri S, Hillyer LM, Cho CE, Ma DWL, Bakovic M.   +9 more
europepmc   +1 more source

Radiosynthesis and evaluation of a carbon-11 labeled PET ligand for imaging of O-GlcNAcase. [PDF]

Am J Nucl Med Mol Imaging
Li Y, Zhou X, Song Z, Zhao T, Rong J, Chen J, Zhao C, Hu Q, Li X, Li C, Sun Z, Gao Y, Patel JS, Chaudhary A, Yuan H, Liang SH.   +15 more
europepmc   +1 more source

Radiolabeling of porcine, murine growth hormone and a potential antagonist G118R-mGH for biodistribution study <i></i>

Amanda Palermo Nunes, Filipe Menezes, Larissa A. Almeida, Stephanie A. Pomin, Patricia Garone Figueira Falcão, Carlos Roberto Jorge Soares   +5 more
openalex   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Impact of Radiolabeling Strategies on the Pharmacokinetics and Distribution of an Anti-PD-L1 PET Ligand.

Molecular Pharmaceutics, 2022
Molecular imaging with PET offers an alternative method to quantify programmed-death-ligand 1 (PD-L1) to accurately select patients for immunotherapies.
V. Tran, Alizée Bouleau, H. Nozach, M. Richard, Céline Chevaleyre, S. Dubois, D. Kereselidze, B. Kuhnast, M. Evans, Simon Specklin, C. Truillet   +10 more
semanticscholar   +1 more source

Anchoring Group Mediated Radiolabeling for Achieving Robust Nanoimaging Probes.

Small, 2021
Radiolabeling counts for much in the functionalization of inorganic nanoparticles (NPs) because it endows NPs with high-sensitive imaging capacities apart from providing accurate pharmacokinetic information on the labeled particles, which makes the ...
Lei Chen, Jianxian Ge, Baoxing Huang, Dandan Zhou, Gang Huang, Jianfeng Zeng, Mingyuan Gao   +6 more
semanticscholar   +1 more source

Preparation, biodistribution and dosimetry study of Tc-99m labeled N-doped graphene quantum dot nanoparticles as a multimodular radiolabeling agent

, 2021
A new Tc-99m N-doped graphene quantum dot 99mTc-(N-GQD) moiety was developed as a radiolabeling agent for molecules lacking chelation or water solubility of ligands simultaneously. (N-GQDs) were synthesized and characterized with high purity (size range =
E. Gharepapagh, A. Fakhari, Tahereh Firuzyar, Ashkan Shomali, F. Azimi   +4 more
semanticscholar   +1 more source

Radiolabeling strategies and pharmacokinetic studies for metal based nanotheranostics.

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2020
Radiolabeled metal-based nanoparticles (MNPs) have drawn considerable attention in the fields of nuclear medicine and molecular imaging, drug delivery, and radiation therapy, given the fact that they can be potentially used as diagnostic imaging and/or ...
S. Ranjbar Bahadori, Aditi Mulgaonkar, R. Hart, Cheng-Yang Wu, Dianbo Zhang, A. Pillai, Y. Hao, Xiankai Sun   +7 more
semanticscholar   +1 more source